Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy

SIMPLE SUMMARY: Recently, high-risk prostate cancer was subdivided to a very-high-risk group considered to have the worst prognosis, including clinical stage T3b–T4, primary Gleason pattern 5, or more than four biopsy cores with Gleason score 8–10. Among these, T3b–T4 stage is a special interest in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Yamazaki, Hideya, Suzuki, Gen, Masui, Koji, Aibe, Norihiro, Shimizu, Daisuke, Kimoto, Takuya, Yoshida, Ken, Nakamura, Satoaki, Okabe, Haruumi
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8070084/
https://ncbi.nlm.nih.gov/pubmed/33924563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13081856
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados